Standout Papers

A CFTR Potentiator in Patients with Cystic Fibrosis and the <i>G551D</i> Mutation 2011 2026 2016 2021 1.5k
  1. A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation (2011)
    Bonnie W. Ramsey, Jane C. Davies et al. New England Journal of Medicine
  2. Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR (2015)
    Claire Wainwright, J.S. Elborn et al. New England Journal of Medicine
  3. Cystic fibrosis (2016)
    J.S. Elborn The Lancet
  4. Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del (2017)
    Jennifer L. Taylor‐Cousar, À. Munck et al. New England Journal of Medicine
  5. Treatment of lung infection in patients with cystic fibrosis: Current and future strategies (2012)
    Gerd Döring, Patrick A. Flume et al. Journal of Cystic Fibrosis

Immediate Impact

3 by Nobel laureates 4 from Science/Nature 77 standout
Sub-graph 1 of 18

Citing Papers

Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
2025 Standout
Polymeric Nanoparticles for Drug Delivery
2024 Standout

Works of J.S. Elborn being referenced

Cystic fibrosis
2016 Standout
Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: Formulation, characterisation and functionalisation with dornase alfa (DNase)
2014
and 1 more

Author Peers

Author Last Decade Papers Cites
J.S. Elborn 14769 2739 4012 549 20.5k
Félix Ratjen 14440 2186 2424 409 17.5k
Michael W. Konstan 14858 2138 2459 234 17.5k
Bonnie W. Ramsey 16111 3371 5404 193 21.0k
Margaret Rosenfeld 12408 2408 2072 214 17.0k
Jane C. Davies 8706 1319 2752 332 12.3k
Frank J. Accurso 9616 1719 1967 182 12.2k
Nanshan Zhong 6702 1856 2365 520 17.3k
Robert A. Wise 15681 5432 3174 832 34.6k
Bruce C. Marshall 9720 2448 1482 136 12.9k
Francesco Blasi 5873 6892 1057 513 15.2k

All Works

Loading papers...

Rankless by CCL
2026